Reuters logo
BRIEF-Intra-Cellular Therapies Q3 loss per share $0.53
November 8, 2017 / 1:29 PM / a month ago

BRIEF-Intra-Cellular Therapies Q3 loss per share $0.53

Nov 8 (Reuters) - Intra-cellular Therapies Inc

* Intra-Cellular Therapies reports third quarter 2017 financial results and provides corporate update

* Q3 loss per share $0.53

* Q3 earnings per share view $-0.62 -- Thomson Reuters I/B/E/S

* Cash, cash equivalents, investment securities totaled $328.1 million at September 30, 2017, versus $384.1 million at December 31, 2016​

* Expect to complete patient enrollment in our bipolar studies in 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below